Your Shopping Cart Is Empty
| Report Code: A01278 | Dec 2021 | Pages: 251 | ||
| Tables: 123 | Charts: 51 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Stents Market
Request Now !The global stents market size was valued at $11,749.4 million in 2020, and is estimated to reach $19,767.5 million by 2030, growing at a CAGR of 5.6% from 2021 to 2030. A stent is defined as a medical device, which is inserted into blocked passageway to keep it open. It is a designed as a tiny tube which restores the flow of blood and other fluids, to different organ of body. Stents are made of either plastic or metal. Stents are known as the largest stents, which are used for removal of blockage from larger arteries. It is coated with drugs to help blocked arteries from closing. Stents are also used to prevent aneurysms from rupturing aorta, brain, or other blood vessels.
The COVID-19 outbreak is anticipated to have a negative impact on the growth of the global stents market. Many hospitals across the globe, including cardiac catheterization were restructured to increase the hospital capacity for patients diagnosed with COVID-19. This leads to cancellation of many non-essential surgical procedures and the quality of care toward patients other than COVID-19 decreases. This has significantly contributed to decline of the global market.
Growth of the global stents market is majorly driven by increase in prevalence of coronary artery disease; advancements in technology for stent development; increase in funding from private & government organizations for development of healthcare sector and research centers; and rise in demand for drug eluting stents. According to Centers for Disease Control and Prevention (CDC), in 2019, it was reported that around 360,900 population die due to coronary artery disease. It is one of the most common type of heart disease. For instance, in August 2021, Sinomed, one of the leading international medical device company, announced the European launch of HT Supreme Drug eluting stent at the University Hospital Galway.
Furthermore, rise in number of approvals for drugs is anticipated to fuel growth of the stent market. For instance, in October 2020, the U.S. Food and Drug Administrative (FDA) announced approval for Venous Self-Expanding Stent system, which is used for treatment of iliofemoral venous outflow obstruction. Moreover, in June 2021, Abbott announced the U.S FDA approval for Abbott XIENCE stent, which is used for high bleeding risk patients.
In addition, rise in geriatric population and increase in number of chronic diseases fuel the stents market growth, owing to the fact that aged individuals are more susceptible to cardiovascular disease. According to the Journal of Jama Cardiology, in 2019, it was reported that approximately 38.0% population die due to heart failure, among which most population are above the age of 65 years. According to the Centers for Disease Control and Prevention (CDC), in September 2021, it was reported that around 18.2 million population above the age of 20 years and older are diagnosed with coronary artery disease.
In September 2020, the U.S. Food and Drug Administrative (FDA) announced the approval of Treo Abdominal stent graft system for the treatment of patient diagnosed with abdominal aortic aneurysms. In addition, unhealthy diet habits and lack of physical activities are gaining traction across the globe, owing to rise in prevalence or cardiovascular diseases. Thus, technological advancements in medical infrastructure and availability of percutaneous coronary intervention (PCI) procedure, propel growth of the market. However, high cost of stents procedure is expected to restrict the stents market growth during the forecast period.
The global stents market is segmented into product, material, end user, and region. By product type, the market is categorized into coronary stents, peripheral stents, and stent related implant.
On the basis of materials, it is divided into polymeric biomaterial, metallic biomaterial, and natural biomaterial. By end user, it market is fragmented into hospital, ambulatory surgical centers, and others. Region-wise, the stents market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and the rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and the rest of LAMEA).
Depending on product, the coronary stents segment dominated the stents market in 2020, and this trend is expected to continue during the forecast period, owing to increase in prevalence of coronary artery disease, advancements in technology in the pharmaceutical & biotechnology industry, and surge in adoption of drug eluting stents. However, the peripheral stents segment is expected to witness considerable growth during the forecast period, owing to increase in prevalence of peripheral artery disease and rise in number of key players for manufacturing of stents.
On the basis of material, the metallic materials segment dominated the stents market in 2020, and this trend is expected to continue during the forecast period, owing to rise in prevalence of cardiovascular disease, increasing number of key players for manufacturing of metallic stents, and surge in number of surgical procedure such as fluoroscopy and endoscopy. However, the polymeric biomaterials segment is expected to witness considerable growth during the forecast period, owing to rise in prevalence of cardiovascular disease, surge in focus of companies to develop and manufacture polymeric stents, and increase in number of approval from the government to develop stents by polymer.
By end user, the hospital segment was the major contributor in 2020, and is expected to maintain its lead during the forecast period, owing to increase in prevalence of coronary artery diseases, initiative taken by government for development of medical infrastructure, rise in awareness about the treatment and management of disease and surge in sedentary life style. However, the ambulatory surgical centers segment is expected to witness considerable growth during the forecast period, owing to advancements in technology in the healthcare sector and rise in demand for angioplasty procedures.
North America garnered the major share in the stents market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of cardiovascular disease, increase in number of approvals for stents product, the development of advanced healthcare infrastructure, the presence of key players for manufacturing stents, and development in technology for healthcare in the region. However, Asia-Pacific is expected to register the highest CAGR of 8.7% from 2021 to 2030, owing to increase in prevalence of coronary artery disease, rise in number of geriatric populations, growth in health care expenditures and increase in adoption of unhealthy lifestyle.
The key players operating in the global Stents market include Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & CO. KG., Boston Scientific Corporation, Becton, Dickinson and Company, Elixir Medical Corporation, Medtronic Plc., Microport Scientific Corporation, Reva Medical, Inc., and Terumo Corporation.
Key Benefits For Stakeholders
Stents Market Report Highlights
| Aspects | Details |
|---|---|
| By Product |
|
| By Material |
|
| By End User |
|
| By Region |
|
| By Key Market Players |
|
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of heart diseases and rise in geriatric population
3.5.1.2.Increase in demand for angioplasty
3.5.1.3.Increase in number of approvals for stents
3.5.2.Restraint
3.5.2.1.High cost of procedures associated with stents
3.5.3.Opportunity
3.5.3.1.Increase in R&D and advancements in technology
3.5.3.2.Increase in healthcare expenditure
3.5.4.Impact analysis
3.6.Impact analysis of COVID-19 on the stents market
CHAPTER 4:STENTS MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Coronary stents
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Coronary stents, by type
4.2.2.1.Market size and forecast
4.2.2.2.Drug-eluting stents (DES)
4.2.2.2.1.Market size and forecast
4.2.2.3.Bare-metal coronary stents
4.2.2.3.1.Market size and forecast
4.2.2.4.Bioabsorbable stents
4.2.2.4.1.Market size and forecast
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country
4.3.Peripheral stents
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Peripheral stents, by type
4.3.2.1.Market size and forecast
4.3.2.2.Iliac stents
4.3.2.2.1.Market size and forecast
4.3.2.3.Femoral-popliteal stents
4.3.2.3.1.Market size and forecast
4.3.2.4.Renal & related stents
4.3.2.4.1.Market size and forecast
4.3.2.5.Carotid stents
4.3.2.5.1.Market size and forecast
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country
4.4.Stents-related implant
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Stents related implant, by type
4.4.2.1.Market size and forecast
4.4.2.2.Synthetic grafts
4.4.2.2.1.Market size and forecast
4.4.2.3.Vena cava filters
4.4.2.3.1.Market size and forecast
4.4.3.Market size and forecast, by region
4.4.4.Market analysis, by country
CHAPTER 5:STENTS MARKET, BY MATERIAL
5.1.Overview
5.1.1.Market size and forecast
5.2.Metallic biomaterials
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Polymer biomaterials
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country
5.4.Natural biomaterials
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country
CHAPTER 6:STENTS MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country
6.3.Ambulatory Surgical Center
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country
6.4.Others
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country
CHAPTER 7:STENTS MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America Stents market, by product
7.2.3.North America Stents market, by material
7.2.4.North America Stents market, by end user
7.2.5.Market size and forecast, by country
7.2.5.1.U.S.
7.2.5.1.1.U.S. Stents market, by product
7.2.5.1.2.U.S. Stents market, by material
7.2.5.1.3.U.S. Stents market, by end user
7.2.5.2.Canada
7.2.5.2.1.Canada Stents market, by product
7.2.5.2.2.Canada Stents market, by material
7.2.5.2.3.Canada Stents market, by end user
7.2.5.3.Mexico
7.2.5.3.1.Mexico Stents market, by product
7.2.5.3.2.Mexico Stents market, by material
7.2.5.3.3.Mexico Stents market, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe Stents market, by product
7.3.3.Europe Stents market, by material
7.3.4.Europe Stents market, by end user
7.3.5.Market size and forecast, by country
7.3.5.1.Germany
7.3.5.1.1.Germany Stents market, by product
7.3.5.1.2.Germany Stents market, by material
7.3.5.1.3.Germany Stents market, by end user
7.3.5.2.France
7.3.5.2.1.France Stents market, by product
7.3.5.2.2.France Stents market, by material
7.3.5.2.3.France Stents market, by end user
7.3.5.3.UK
7.3.5.3.1.UK Stents market, by product
7.3.5.3.2.UK Stents market, by material
7.3.5.3.3.UK Stents market, by end user
7.3.5.4.Italy
7.3.5.4.1.Italy Stents market, by product
7.3.5.4.2.Italy Stents market, by material
7.3.5.4.3.Italy Stents market, by end user
7.3.5.5.Spain
7.3.5.5.1.Spain Stents market, by product
7.3.5.5.2.Spain Stents market, by material
7.3.5.5.3.Spain Stents market, by end user
7.3.5.6.Rest of Europe
7.3.5.6.1.Rest of Europe Stents market, by product
7.3.5.6.2.Rest of Europe Stents market, by material
7.3.5.6.3.Rest of Europe Stents market, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific Stents market, by product
7.4.3.Asia-Pacific Stents market, by material
7.4.4.Asia-Pacific Stents market, by end user
7.4.5.Market size and forecast, by country
7.4.5.1.China
7.4.5.1.1.China Stents market, by product
7.4.5.1.2.China Stents market, by material
7.4.5.1.3.China Stents market, by end user
7.4.5.2.Japan
7.4.5.2.1.Japan Stents market, by product
7.4.5.2.2.Japan Stents market, by material
7.4.5.2.3.Japan Stents market, by end user
7.4.5.3.India
7.4.5.3.1.India Stents market, by product
7.4.5.3.2.India Stents market, by material
7.4.5.3.3.India Stents market, by end user
7.4.5.4.Australia
7.4.5.4.1.Australia Stents market, by product
7.4.5.4.2.Australia Stents market, by material
7.4.5.4.3.Australia Stents market, by end user
7.4.5.5.Rest of Asia-Pacific
7.4.5.5.1.Rest of Asia-Pacific Stents market, by product
7.4.5.5.2.Rest of Asia-Pacific Stents market, by material
7.4.5.5.3.Rest of Asia-Pacific Stents market, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA Stents market, by product
7.5.3.LAMEA Stents market, by material
7.5.4.LAMEA Stents market, by end user
7.5.5.Market size and forecast, by country
7.5.5.1.Brazil
7.5.5.1.1.Brazil Stents market, by product
7.5.5.1.2.Brazil Stents market, by material
7.5.5.1.3.Brazil Stents market, by end user
7.5.5.2.Saudi Arabia
7.5.5.2.1.Saudi Arabia Stents market, by product
7.5.5.2.2.Saudi Arabia Stents market, by material
7.5.5.2.3.Saudi Arabia Stents market, by end user
7.5.5.3.South Africa
7.5.5.3.1.South Africa Stents market, by product
7.5.5.3.2.South Africa Stents market, by material
7.5.5.3.3.South Africa Stents market, by end user
7.5.5.4.Rest of LAMEA
7.5.5.4.1.Rest of LAMEA Stents market, by product
7.5.5.4.2.Rest of LAMEA Stents market, by material
7.5.5.4.3.Rest of LAMEA Stents market, by end user
CHAPTER 8:COMPANY PROFILES
8.1.ABBOTT LABORATORIES
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.B. BRAUN MELSUNGEN AG
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.BIOTRONIK SE & CO. KG
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Key strategic moves and developments
8.4.BOSTON SCIENTIFIC CORPORATION
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance
8.4.6.Key strategic moves and developments
8.5.BECTON, DICKINSON AND COMPANY
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments
8.6.ELIXIR MEDICAL CORPORATION
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Key strategic moves and developments
8.7.MEDTRONIC PLC
8.7.1.Company overview
8.7.2.Operating business segments
8.7.3.Product portfolio
8.7.4.Business performance
8.8.MICROPORT SCIENTIFIC CORPORATION
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments
8.9.REVA MEDICAL, INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Product portfolio
8.10.TERUMO CORPORATION
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 02.STENTS MARKET, BY CORONARY STENTS, 2020–2030 ($MILLION)
TABLE 03.STENTS MARKET FOR CORONARY STENTS, BY REGION, 2020–2030 ($MILLION)
TABLE 04.STENTS MARKET, BY PERIPHERAL STENTS, 2020–2030 ($MILLION)
TABLE 05.STENTS MARKET FOR PERIPHERAL STENTS, BY REGION, 2020–2030 ($MILLION)
TABLE 06.STENTS MARKET, BY STENTS-RELATED IMPLANT, 2020–2030 ($MILLION)
TABLE 07.STENTS MARKET FOR PERIPHERAL STENTS, BY REGION, 2020–2030 ($MILLION)
TABLE 08.STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 09.STENTS MARKET FOR METALLIC BIOMATERIALS, BY REGION, 2020–2030 ($MILLION)
TABLE 10.STENTS MARKET FOR POLYMER BIOMATERIALS, BY REGION, 2020–2030 ($MILLION)
TABLE 11.STENTS MARKET FOR NATURAL BIOMATERIALS, BY REGION, 2020–2030 ($MILLION)
TABLE 12.STENTS MARKET, BY HOSPITAL, 2020–2030 ($MILLION)
TABLE 13.STENTS MARKET FOR HOSPITALS, BY REGION, 2020–2030 ($MILLION)
TABLE 14.STENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2030 ($MILLION)
TABLE 15.STENTS MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 16.STENTS MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 17.NORTH AMERICA STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 18.NORTH AMERICA STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 19.NORTH AMERICA STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 20.NORTH AMERICA STENTS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 21.U.S. STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 22.U.S. STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 23.U.S. STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 24.CANADA STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 25.CANADA STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 26.CANADA STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 27.MEXICO STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 28.MEXICO STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 29.MEXICO STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 30.EUROPE STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 31.EUROPE STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 32.EUROPE STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 33.EUROPE STENTS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 34.GERMANY STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 35.GERMANY STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 36.GERMANY STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 37.FRANCE STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 38.FRANCE STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 39.FRANCE STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 40.UK STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 41.UK STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 42.UK STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 43.ITALY STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 44.ITALY STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 45.ITALY STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 46.SPAIN STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 47.SPAIN STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 48.SPAIN STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 49.REST OF EUROPE STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 50.REST OF EUROPE STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 51.REST OF EUROPE STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 52.ASIA-PACIFIC STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 53.ASIA-PACIFIC STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 54.ASIA-PACIFIC STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 55.ASIA-PACIFIC STENTS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 56.CHINA STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 57.CHINA STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 58.CHINA STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 59.JAPAN STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 60.JAPAN STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 61.JAPAN STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 62.INDIA STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 63.INDIA STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 64.INDIA STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 65.AUSTRALIA STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 66.AUSTRALIA STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 67.AUSTRALIA STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 69.REST OF ASIA-PACIFIC STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 70.REST OF ASIA-PACIFIC STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 71.LAMEA STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 72.LAMEA STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 73.LAMEA STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 74.LAMEA STENTS MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 75.BRAZIL STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 76.BRAZIL STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 77.BRAZIL STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 78.SAUDI ARABIA STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 79.SAUDI ARABIA STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 80.SAUDI ARABIA STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 81.SOUTH AFRICA STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 82.SOUTH AFRICA STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 83.SOUTH AFRICA STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 84.REST OF LAMEA STENTS MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 85.REST OF LAMEA STENTS MARKET, BY MATERIAL, 2020–2030 ($MILLION)
TABLE 86.REST OF LAMEA STENTS MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 87.ABBOTT: COMPANY SNAPSHOT
TABLE 88.ABBOTT: OPERATING SEGMENT
TABLE 89.ABBOTT: PRODUCT PORTFOLIO
TABLE 90.ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 91.B. BRAUN: COMPANY SNAPSHOT
TABLE 92.B. BRAUN: OERATING SEGMENT
TABLE 93.B. BRAUN: PRODUCT PORTFOLIO
TABLE 94.B. BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95.BIOTRONIK: COMPANY SNAPSHOT
TABLE 96.BIOTRONIK: OERATING SEGMENT
TABLE 97.BIOTRONIK: PRODUCT PORTFOLIO
TABLE 98.BIOTRONIK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99.BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 100.BOSTON SCIENTIFIC: OERATING SEGMENT
TABLE 101.BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 102.BOSTON SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103.BD: COMPANY SNAPSHOT
TABLE 104.BD: OERATING SEGMENT
TABLE 105.BD: PRODUCT PORTFOLIO
TABLE 106.BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107.ELIXIR MEDICAL: COMPANY SNAPSHOT
TABLE 108.ELIXIR MEDICAL: OERATING SEGMENT
TABLE 109.ELIXIR MEDICAL: PRODUCT PORTFOLIO
TABLE 110.ELIXIR MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 111.MEDTRONIC: COMPANY SNAPSHOT
TABLE 112.MEDTRONIC: OERATING SEGMENT
TABLE 113.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 114.MICROPORT: COMPANY SNAPSHOT
TABLE 115.MICROPORT: OERATING SEGMENT
TABLE 116.MICROPORT: PRODUCT PORTFOLIO
TABLE 117.MICROPORT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 118.REVA MEDICAL: COMPANY SNAPSHOT
TABLE 119.REVA MEDICAL: PRODUCT PORTFOLIO
TABLE 120.TERUMO: COMPANY SNAPSHOT
TABLE 121.TERUMO: OERATING SEGMENT
TABLE 122.TERUMO: PRODUCT PORTFOLIO
TABLE 123.TERUMO: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 01.STENTS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2019–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2019–2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.STENTS MARKET BY CORONARY STENTS, 2020–2030 ($MILLION)
FIGURE 14.STENTS MARKET BY BARE-METAL CORONARY STENTS, 2020–2030 ($MILLION)
FIGURE 15.STENTS MARKET BY BIOABSORBABLE STENTS, 2020–2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF STENTS MARKET FOR CORONARY STENTS, BY COUNTRY, 2020–2030 (%)
FIGURE 17.STENTS MARKET BY ILIAC STENTS, 2020–2030 ($MILLION)
FIGURE 18.STENTS MARKET BY FEMORAL-POPLITEAL STENTS, 2020–2030 ($MILLION)
FIGURE 19.STENTS MARKET BY RENAL & RELATED STENTS, 2020–2030 ($MILLION)
FIGURE 20.STENTS MARKET BY CAROTID STENTS, 2020–2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF STENTS MARKET FOR PERIPHERAL STENTS, BY COUNTRY, 2020–2030 (%)
FIGURE 22.STENTS MARKET BY SYNTHETIC GRAFTS, 2020–2030 ($MILLION)
FIGURE 23.STENTS MARKET BY VENA CAVA FILTERS, 2020–2030 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF STENTS MARKET FOR PERIPHERAL STENTS, BY COUNTRY, 2020–2030 (%)
FIGURE 25.COMPARATIVE ANALYSIS OF STENTS MARKET FOR METALLIC BIOMATERIALS, BY COUNTRY, 2020–2030 (%)
FIGURE 26.COMPARATIVE ANALYSIS OF STENTS MARKET FOR POLYMER BIOMATERIALS, BY COUNTRY, 2020–2030 (%)
FIGURE 27.COMPARATIVE ANALYSIS OF STENTS MARKET FOR NATURAL BIOMATERIALS, BY COUNTRY, 2020–2030 (%)
FIGURE 28.COMPARATIVE ANALYSIS OF STENTS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2030 (%)
FIGURE 29.COMPARATIVE ANALYSIS OF STENTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020–2030 (%)
FIGURE 30.COMPARATIVE ANALYSIS OF STENTS MARKET FOR OTHERS, BY COUNTRY, 2020–2030 (%)
FIGURE 31.ABBOTT: NET SALES, 2018–2020 ($MILLION)
FIGURE 32.ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33.ABBOTT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 34.B. BRAUN: NET SALES, 2018–2020 ($MILLION)
FIGURE 35.B. BRAUN: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 36.B. BRAUN: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 37.BOSTON SCIENTIFIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 38.BOSTON SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 39.BOSTON SCIENTIFIC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 40.BD: NET SALES, 2018–2020 ($MILLION)
FIGURE 41.BD: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 42.BD: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 43.MEDTRONIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 44.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 45.MEDTRONIC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 46.MICROPORT: NET SALES, 2018–2020 ($MILLION)
FIGURE 47.MICROPORT: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 48.MICROPORT: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 49.TERUMO: NET SALES, 2018–2020 ($MILLION)
FIGURE 50.TERUMO: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 51.TERUMO: REVENUE SHARE, BY REGION, 2020 (%)
Growth of the stents market is attributed to factors such as advancements in technology in the healthcare sector; rise in prevalence of cardiovascular diseases; increase in funds from private and government organizations for development of healthcare infrastructure; and rise in number of angioplasty procedure. The stents market gains interest of medical device and biotechnology companies, owing to increase in adoption of drug eluting stents. Moreover, the stents market has gained immense interest in the hospital sector over the years as these are used for treatment of cardiac diseases such as coronary artery disease and peripheral artery disease.
North America is expected to witness highest growth, in terms of revenue, owing to rise in prevalence of cardiac disorder, growth in demand for minimally invasive procedures, and increase in geriatric population in the region.
Asia-Pacific was the second largest contributor to the market in 2020, and is expected to register the fastest CAGR during the forecast period, owing to increase in prevalence of cardiovascular diseases, rise in number of populations, growth in health care expenditures, and lack of physical activities.
However, high cost associated with stents procedure is anticipated to restrain the market growth during the forecast period.
A. A stent is a tube like implant that is implanted into the lumen of any blood vessel or a duct in order to keep the passage open.
A. Stents are small, expandable tubes that treat narrowed arteries in your body. In people with coronary heart disease caused by the buildup of plaque, they can: Open narrowed arteries. Reduce symptoms, like chest pain.
A. The total market value of stents market is $11,749.4 million in 2020.
A. The forecast period in the report is from 2021 to 2030
A. The market value of stents market in 2021 was $12,113.6 million
A. The base year for the report is 2020.
A. Yes, stents companies are profiled in the report
A. The top companies that hold the market share in stents market are Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & CO. KG., Boston Scientific Corporation, Becton, Dickinson and Company, Elixir Medical Corporation, Medtronic Plc., Microport Scientific Corporation, Reva Medical, Inc., and Terumo Corporation.
A. Asia-Pacific is expected to register the highest CAGR of 7.3% from 2021 to 2030, owing to increase in prevalence of coronary artery diseases, rise in number of populations, growth in health care expenditures, and rise in sedentary lifestyle
A. The key trends in the stents market are by increase in number of geriatric populations, advancements in R&D activities in healthcare sector, and increase in number of drug approvals for use of stents due to coronary and peripheral artery diseases
Start reading instantly.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report